You are hereFebruary 7, 2019
Kick-starting the Genome in early Development
CAMBRIDGE (UK), February 2019 — Think of the egg and sperm as information capsules with stored instructions for starting a new life. But post-fertilization, what kickstarts the interpretation of these instructions?
Researchers at the Babraham Institute in Cambridge have provided further pieces of the puzzle by using a rare subset of mouse embryonic stem cells that provide a “lookalike” system to the two-cell embryo (zygote) occurring 24 hours post-fertilization in pregnant mice. This is the stage at which the zygotic genome is normally activated. Using these cells, called 2C-like cells, the researchers could probe the hierarchy of molecular events taking place to initiate the zygotic genome.
Their research findings are published in Genes & Development.
Waking up the genome occurs through events called the minor wave and major wave. Researchers knew that a transcription factor (a protein that binds DNA to promote expression) called Dux activated a range of genes in the second major wave, but not what initiated Dux or the genome activation in the first place.
“Genome activation is the first thing that the embryo has to do,” said Melanie Eckersley-Maslin, a postdoctoral researcher at the Babraham Institute. “Despite it being crucial to the formation of the embryo, we know surprisingly little about it. The 2C-like system provides an experimental approximation of those very early embryo cells and allows us to use the full arsenal of research techniques available to tease apart what is happening.”
The researchers started by screening for factors that increased the number of the rare 2C-like cells in a population of mouse embryonic stem cells – indicating positive factors that were able to promote genome activation. The researchers identified two proteins called development pluripotency associated 2 (Dppa2) and 4 (Dppa4).
“Looking at what we have discovered about Dppa2 and Dppa4 they fit the profile of being responsible for kick-starting the expression of the new genome,” explained Dr. Eckersley-Maslin. “The proteins are already present in the egg, so are already there before the new embryo is formed, and if we delete the Dppa2 and 4 genes from the genome we see a loss of 2C-like cells and the loss of the Dux-initiated wave of genome expression.”
The model proposed by the research connects genome activation with epigenetic reprogramming of the cells that eventually form the sperm and eggs, forming a connected chain of events that secures Dppa2 and 4 expression in egg cells ready to initiate genome activation when the time is right
“Looking forward, it will be interesting to uncover the details of genome activation in human development as this is an unexplored area,” commented Wolf Reik, M.D., Ph.D., head of the epigenetics research program at the Babraham Institute and associate faculty member at the Wellcome Sanger Institute. “Understanding more about regulators of the genome in early life is also relevant to situations where we wish to revert cells to their early-life state, such as in generating induced pluripotent stem cells for future therapeutic uses.”
Merged image showing a colony of mouse embryonic stem cells fluorescently stained for Dppa2 in red, Dppa4 in green and DNA in blue. Image courtesy of Dr. Melanie Eckersley-Maslin, Babraham Institute.